This inventor holds 3 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 2010-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Villafranca di Verona, IT (2010)
- Iocalita' Santa Lucia ai Monti, IT (2013)
- Santa Lucia ai Monti, IT (2016)
Company Filing History:
Years Active: 2010-2016
Title: Paolo Francesco Fabene: Innovator in Epilepsy Treatment
Introduction
Paolo Francesco Fabene is a notable inventor based in Santa Lucia ai Monti, Italy. He has made significant contributions to the field of medical research, particularly in the treatment of seizures and epilepsy. With a total of 3 patents, his work focuses on innovative therapies that address critical health issues.
Latest Patents
One of Fabene's latest patents is centered on anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy. This patent outlines methods for the prevention and treatment of these conditions, emphasizing the role of leukocyte recruitment in the pathogenesis of epilepsy. The research demonstrates that treatment with agents that inhibit leukocyte recruitment can have both therapeutic and preventative effects in blocking recurrent seizures and epilepsy.
Career Highlights
Fabene is affiliated with Leland Stanford Junior University, where he continues to advance his research and contribute to the scientific community. His work has garnered attention for its potential to improve the quality of life for individuals suffering from epilepsy.
Collaborations
Throughout his career, Fabene has collaborated with esteemed colleagues, including Eugene C Butcher and Gabriela Constantin. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Paolo Francesco Fabene is a pioneering inventor whose work in epilepsy treatment showcases the importance of innovative research in medicine. His contributions are paving the way for new therapeutic approaches that could significantly benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
